EUROVULCAN 2 | Panel #3: Regulators Moving to FHIR with support from the Vulcan Accelerator

Chair: Hugh Glover, Technical Director, Vulcan

Panelists & topics:

• • What’s next in CDISC for Vulcan: Peter Van Reusel, Chief Standards Officer, CDISC
  • What’s next in US Policy for Vulcan: Stephen Konya, Senior Advisor to the Deputy National Coordinator for Health IT and Innovative Portfolio Lead, U.S. Department of Health and Human Services (HHS), Office of the National Coordinator for Health IT
  • What’s next in personalized eLabeling for Vulcan: Craig Anderson (online), Co-Lead, Vulcan | WP5 Industry Co-lead, Gravitate-Health | Pfizer
  • What’s next in the HL7 FHIR Connectathon for the GIDWG/UNICOM/ePI track after the Athens Marathon: Joao Almeida , Chair, HL7 Portugal | Product owner Gravitate-Health
  • Can Clinical Care Data (RWD) Replace Clinical Research Data?: W. Ed Hammond, Director, Duke Center for Health Informatics, Clinical and Translational Science Institute
  • Implications for Xt-EHR & secondary use of data in the EHDS: Christos N. Schizas, President of the National eHealth Authority of Cyprus (NeHA) | Coordinator of Xt-EHR

 

Closing Remarks

Michael van Campen*, Program Director, Vulcan

Amy Cramer, Co-Chair, Vulcan

 

Rapporteurs: Mina Boumbaki*, Head of the eHealth Services Department, Ministry of Health, Greece, Elena Petelos, University of Maastricht | Chair Real-World Evidence and Artificial Intelligence IG, HTAi | President Global Health initiative, EUPHA.

*Speakers invited – TBC